Conversion of systemic lupus erythematosus to common variable hypogammaglobulinemia (Q38704398)

5 September 2017

1 reference

title

Conversion of systemic lupus erythematosus to common variable hypogammaglobulinemia (English)

1 reference

systemic lupus erythematosus

5 September 2017

main subject

1 reference

Baum CG

1 reference

5 September 2017

Chiorazzi N

series ordinal

1 reference

5 September 2017

Frankel S

series ordinal

1 reference

5 September 2017

Shepherd GM

series ordinal

1 reference

5 September 2017

language of work or name

English

0 references

publication date

1 October 1989

1 reference

American Journal of Medicine

5 September 2017

published in

1 reference

5 September 2017

1 reference

5 September 2017

1 reference

5 September 2017

page(s)

449-456

1 reference

Concurrent systemic lupus erythematosus and common variable hypogammaglobulinemia

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

Transition from systemic lupus erythematosus to common variable hypogammaglobulinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

Development of hypogammaglobulinemia in a patient with systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

Panhypogammaglobulinemia in systemic lupus erythematosus: in vitro demonstration of multiple cellular defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

Immunodeficiency with hyper IgM after systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

Permanent intrinsic B cell immunodeficiency caused by phenytoin hypersensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

Stimulation of a subset of normal resting T lymphocytes by a monoclonal antibody to a crossreactive determinant of the human T cell antigen receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

Immune function in systemic lupus erythematosus. Impairment of in vitro T-cell proliferation and in vivo antibody response to exogenous antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

Induction of Human Antibody Responses In Vitro with Emphasis on Allogeneic Helper Factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

A plaque assay for all cells secreting Ig of a given type or class

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

Right angle light scatter: a necessary parameter in flow cytofluorimetric analysis of human peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

Effects of corticosteroids on immunity in man. I. Decreased serum IgG concentration caused by 3 or 5 days of high doses of methylprednisolone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

Heterogeneity of "acquired" or common variable agammaglobulinemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

Profile of multiple lymphocyte functional defects in acquired hypogrammaglobulinemia, derived from in vitro cell recombination analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

Role of Helper, Suppressor and B-Cell Defects in the Pathogenesis of the Hypogammaglobulinemias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

Studies of immune functions of patients with systemic lupus erythematosus. i. dysfunction of suppressor t‐cell activity related to impaired generation of, rather than response to, suppressor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

Induction of Suppressor T Cells in Systemic Lupus Erythematosus by Thymosin and Cultured Thymic Epithelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

Suppressor cell function defect in idiopathic systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

Heterogeneity of the spontaneously expanded and mitogen-induced generation of suppressor cell function of T cells on B cells in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

Studies of immune functions of patients with systemic lupus erythematosus. V. T cell suppressor function and autologous mixed lymphocyte reaction during active and inactive phases of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

Peripheral Blood Lymphocyte Cell Surface Markers during the Course of Systemic Lupus Erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

Lymphocyte subsets in patients with systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

B cell and T cell lymphopenia in systemic lupus erythematosus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

Analyses of lymphocytes from patients with rheumatoid arthritis and systemic lupus erythematosus. Occurrence of interfering cold-reactive antilymphocyte antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

Comparison of circulating T and B lymphocytes in discoid versus systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

Type I dysgammaglobulinemia, systemic lupus erythematosus and lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

Incidence of cancer in 98 patients with common varied immunodeficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

Effects of phenytoin on man's immunity. Evaluation of changes in serum immunoglobulins, complement, and antinuclear antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

The reversibility of phenytoin-induced IgA deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

Transient antibody deficiency and abnormal t-suppressor cells induced by phenytoin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980831-9

10.1016/S0002-9343(89)80831-9

7 January 2021

Identifiers

DOI

1 reference

5 September 2017

1 reference